{
    "nctId": "NCT04842409",
    "briefTitle": "Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery",
    "officialTitle": "Cardiological Monitoring and Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery for Patients Affected by Breast Cancer: an Observational Prospective Cohort Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Radiotherapy Side Effect",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Change from baseline 3-dimensional left ventricular ejection fraction (3D-LVEF) at 12 months",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Invasive and ductal carcinoma in situ (DCIS) breast cancer\n* Indication to ultra-hypofractionated whole breast irradiation\n* Written informed consent\n* Aged more than 18 years old\n\nExclusion Criteria:\n\n* Neoadjuvant and adjuvant chemotherapy\n* Tumor bed radiation boost prescription",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}